Bionaut Labs develops microscale robots that utilize magnetic propulsion to navigate complex 3D trajectories within the human body, enabling localized delivery of biologics and small molecule therapies to targeted areas of severe brain disorders. This technology addresses the challenge of accessing deep anatomical regions for precise treatment and diagnostic detection, enhancing safety and efficacy in patient care.
Funding
$83M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many severe brain disorders are difficult to treat due to the challenge of delivering therapies precisely to deep anatomical regions within the brain. Traditional methods lack the ability to target specific areas effectively, potentially leading to off-target effects and reduced therapeutic efficacy.
Solution
Bionaut Labs is developing microscale robots, called Bionauts, that use magnetic propulsion to navigate complex 3D trajectories within the human body. These wirelessly controlled micro-robots enable localized delivery of biologics and small molecule therapies directly to targeted areas affected by severe brain disorders. The technology aims to overcome the limitations of conventional drug delivery by providing accurate and direct access to complex human anatomy, enhancing both safety and efficacy. Bionauts are introduced into the body using a standard intrathecal injection needle and guided via external magnetic propulsion systems. After the pre-planned intervention, the Bionaut is guided back to the point of entry for retrieval.
Target Audience
The primary target audience includes medical professionals and researchers focused on treating severe brain disorders requiring precise and localized therapeutic interventions.
Features
- Microscale robots capable of navigating complex 3D trajectories within the human body
- Magnetic propulsion system for precise and controlled movement
- Localized delivery of biologics and small molecule therapies
- Automated guidance system tailored for each procedure and patient
- Retrieval of the Bionaut to the point of entry post-procedure